Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin

Department of Microbiology, School of Medicine, Kyung Hee University, Seoul, Korea.
Journal of Pineal Research (Impact Factor: 7.81). 06/2012; 54(1). DOI: 10.1111/j.1600-079X.2012.01027.x
Source: PubMed

ABSTRACT Epigenetic alterations have emerged as an important mechanism involved in tumorigenesis. The epigenetic impact of DNA methylation in various types of human cancer is not completely understood. Previously, we observed melatonin-induced differential expression of miRNA and miRNA-related genes in human breast cancer cell lines that indicated an anticancer effect of melatonin. In this report, we further characterized epigenetic changes in melatonin-exposed MCF-7 cells through the analysis of DNA methylation profiles in breast cancer cells to provide new insights into the potential mechanisms of the anticancer effect of melatonin. Microarray-based DNA methylation and gene expression profiling were carried out using human breast cancer cell lines. We further identified a number of mRNAs whose expression levels show an inverse correlation with DNA methylation levels. The mRNA expression levels and methylation status of candidate genes in melatonin-exposed cells were confirmed by real-time quantitative PCR and bisulfite PCR. This approach led to the detection of cancer-related genes, which were oncogenic genes, including EGR3 and POU4F2/Brn-3b were down-regulated, while the tumor suppressor gene, GPC3, was up-regulated by 1 nm melatonin-treated MCF-7 cells. Our results provide detailed insights into the DNA methylation patterns induced by melatonin and suggest a potential mechanism of the anticancer effect of aberrant DNA methylation in melatonin-treated breast cancer cells.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Myricetin is a dietary flavonoid that is found in many fruits, vegetables, teas and medicinal herbs. It has been demonstrated to have antioxidative, antiapoptotic, and anti-inflammatory properties, but the precise mechanism underlying the effects of myricetin at the transcriptional level has not yet been determined. The present study aimed to determine the target genes of myricetin in human umbilical vein endothelial cells (HUVECs) by microarray gene expression profiling. Among the more than 40,000 genes investigated, 121 and 953 genes were upregulated by at least 1.5-fold, while 584 and 1426 genes were downregulated by at least 1.5-fold in 24 h for 25 μM and 100 μM myricetin treatment. Gene ontology (GO) analysis showed that the top biological processes disturbed in HUVECs were regulation of apoptosis and cellular metabolic processes. Furthermore, vascular diseaserelated genes including HIRA, HDAC9, HIF1A, and RTN3 were also altered by myricetin. These results demonstrate myricetin-induced genome-wide alterations in the expression profile of HUVECs and suggest that myricetin exerts a vasculoprotective effect through transcriptional changes in the human endothelium. In conclusion, our data support the view that myricetinstimulated changes in gene expression contribute to protective effects on vascular disease.
    BioChip journal 12/2013; 7(4):335-343. DOI:10.1007/s13206-013-7404-4 · 1.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Melatonin is secreted by the pineal gland and gastrointestinal tract and plays a role in circadian rhythm synchronization. Melatonin is also reported to have various physiological effects on endothelial cells. Endothelial cells are responsible for physiologic homeostasis and maintaining blood vessel peuneability in vivo. In this study, using gene expression profiling, we confirmed about 151 up-regulation and 1,023 down-regulation expression genes, with an expression level difference of > 1.5-fold, after exposure to 100 mu M and 1 mM melatonin concentrations in endothelial cells. The genes were classified into 16 functional groups based on their functions, including cell adhesion, immune response, lipid metabolism, and response to stress. We analyzed the gene expression profiling data of melatonin-treated human umbilical vein endothelial cells (HUVECs), which indicated a broad spectrum of physiological functions, including anti-oxidative/anti-inflammatory effects and cell-to-cell junction maintenance-related genes.
    BioChip journal 06/2014; 8(2):91-101. DOI:10.1007/s13206-014-8204-1 · 1.05 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Melatonin is a highly pleiotropic regulator molecule, which influences numerous functions in almost every organ and, thus, up- or down-regulates many genes, frequently in a circadian manner. Our understanding of the mechanisms controlling gene expression is actually now expanding to a previously unforeseen extent. In addition to classic actions of transcription factors, gene expression is induced, suppressed or modulated by a number of RNAs and proteins, such as miRNAs, lncRNAs, piRNAs, antisense transcripts, deadenylases, DNA methyltransferases, histone methylation complexes, histone demethylases, histone acetyltransferases and histone deacetylases. Direct or indirect evidence for involvement of melatonin in this network of players has originated in different fields, including studies on central and peripheral circadian oscillators, shift work, cancer, inflammation, oxidative stress, aging, energy expenditure/obesity, diabetes type 2, neuropsychiatric disorders, and neurogenesis. Some of the novel modulators have also been shown to participate in the control of melatonin biosynthesis and melatonin receptor expression. Future work will need to augment the body of evidence on direct epigenetic actions of melatonin and to systematically investigate its role within the network of oscillating epigenetic factors. Moreover, it will be necessary to discriminate between effects observed under conditions of well-operating and deregulated circadian clocks, and to explore the possibilities of correcting epigenetic malprogramming by melatonin.
    International Journal of Molecular Sciences 10/2014; 15(10):18221-18252. DOI:10.3390/ijms151018221 · 2.34 Impact Factor